TG Therapeutics Raises FY2026 Sales Guidance from $875.000M-$900.000M to $925.000M vs $906.021M Est

Benzinga Newsdesk www.benzinga.com Positive 92.7%

Neg 0% Neu 0% Pos 92.7%

Comments

No comments yet. Be the first!